BeOne Medicines (ONC) Operating Margin (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Operating Margin data on file, last reported at 16.51% in Q1 2026.

• On a quarterly basis, Operating Margin rose 1552.0% year-over-year to 16.51% in Q1 2026; TTM through Mar 2026 was 11.95%, a 1903.0% increase from a year earlier, with the FY2025 full-year figure at 8.37%, up 2328.0% from the prior year.
• Operating Margin for Q1 2026 stood at 16.51%, up from 12.35% in the prior quarter.
• Over the last five years, Operating Margin for ONC reached as high as 16.51% in Q1 2026 and fell as low as 144.57% in Q1 2022.
• Historically, Operating Margin has averaged 43.58% across 5 years, with a median of 17.15% in 2023.
• On a YoY basis, Operating Margin climbed as much as 18794 bps in 2022 and fell as far as 21235 bps in 2022.
• Year by year, Operating Margin stood at 123.29% in 2022, then jumped by 51 bps to 60.5% in 2023, then jumped by 88 bps to 7.04% in 2024, then jumped by 275 bps to 12.35% in 2025, then surged by 34 bps to 16.51% in 2026.
• Per Business Quant data, the three most recent Operating Margin figures were 16.51% in Q1 2026, 12.35% in Q4 2025, and 11.55% in Q3 2025.